Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
public offering
Biotech
Day One spends day 2 hitting up public markets for $150M
Just two days after Day One doubled shares on a data drop for its pediatric brain cancer drug, the biotech is circling up to raise some cash.
Gabrielle Masson
Jun 15, 2022 11:16am
Zai Lab aims for $750M to bankroll licensing deals
Apr 20, 2021 3:30pm
Annexon, AlloVir gun for $100M IPOs
Jul 7, 2020 8:05am
Twist Bioscience nets $140M plus a slew of new DNA partnerships
Feb 26, 2020 12:03pm
Axovant buys more gene therapies, looking toward a busy 2019
Dec 14, 2018 7:42am
AI data miner Sensyne Health looks to go public with $77M listing
Aug 7, 2018 8:46pm